Literature DB >> 2029507

Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.

E Heilmann1, P Hourdillé, A Pruvost, A Paponneau, A T Nurden.   

Abstract

The role of glycoprotein (GP) IIb-IIIa complexes and of adhesive proteins in mediating platelet aggregation is now well defined. However, less is known of the changes that occur once aggregation has begun. We report immunogold staining of thin sections of platelets or platelet aggregates, embedded in Lowicryl K4M, after the use of polyclonal antibodies to GP IIb or GP IIIa, fibrinogen (Fg), von Willebrand factor (vWF), and thrombospondin (TSP). Bound immunoglobulin G (IgG) was located by species-specific anti-IgG coupled to 5-nm gold particles and by electron microscopy. Initial experiments with platelet-rich plasma confirmed the feasibility of visualizing adhesive proteins between platelets in aggregates. Experiments then continued, using stirred suspensions of washed platelets incubated with alpha-thrombin. After 20 seconds, platelets were in contact without detectable release, although giant secretory vesicles containing adhesive proteins were seen. Internal pools of GP IIb-IIIa were progressively externalized within the aggregate. Secreted Fg was readily detected between platelets at 40 seconds. After 3 minutes, when most of the secretion had occurred, Fg had a patchwork-like distribution within the aggregate. After 6 minutes, zones with closely interspaced surface membranes, usually representing pseudopods, were dominant and Fg free. Results for vWF and TSP were similar to those for Fg. Nonetheless, GP IIb-IIIa complexes continued to be located between adjacent surface membranes throughout the aggregate. Thrombin-induced platelet aggregates were isolated, and sodium dodecyl sulfate-soluble extracts were obtained. Western blot experiments showed that, although fibrinopeptide A had been cleaved, degradation of adhesive proteins by platelet proteases had not occurred. These results emphasize that a platelet aggregate is a dynamic structure and suggest that not all surface-contact interactions are mediated by Fg or the other adhesive proteins tested in this study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2029507     DOI: 10.1161/01.atv.11.3.704

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  5 in total

1.  Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.

Authors:  B S Coller; J L Kutok; L E Scudder; D K Galanakis; S M West; G S Rudomen; K T Springer
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism.

Authors:  Anne Saumet; Nando de Jesus; Chantal Legrand; Véronique Dubernard
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.

Authors:  P Nurden; P Savi; E Heilmann; C Bihour; J M Herbert; J P Maffrand; A Nurden
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

Authors:  H F Heynen; M Lozano Molero; P G de Groot; H K Nieuwenhuis; J J Sixma
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.

Authors:  Carsten Deppermann; Deya Cherpokova; Paquita Nurden; Jan-Niklas Schulz; Ina Thielmann; Peter Kraft; Timo Vögtle; Christoph Kleinschnitz; Sebastian Dütting; Georg Krohne; Sabine A Eming; Alan T Nurden; Beate Eckes; Guido Stoll; David Stegner; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.